Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyasu Akatsu

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Journal of Alzheimer'S Disease : JAD|July 13, 2017
Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and HistopathologyAtsushi Niwa, Yuichiro Ii, Akihiro Shindo, et al.
Nature Communications|February 1, 2018
Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathologyKyota Fujita, Xigui Chen, Hidenori Homma, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2017
Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer's pathologyZui Zhang, Yoshiko Takeda-Uchimura, Tahmina Foyez, et al.
Scientific Reports|November 21, 2014
DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's diseaseDai Yuki, Yuki Sugiura, Nobuhiro Zaima, et al.
The Journal of Biological Chemistry|October 5, 2010
Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 functionHirohisa Minagawa, Atsushi Watanabe, Hiroyasu Akatsu, et al.
Acta Neuropathologica|May 5, 2022
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, et al.
Plos One|April 14, 2015
Phosphatidylinositol-glycan-phospholipase D is involved in neurodegeneration in prion diseaseJae-Kwang Jin, Byungki Jang, Hyoung Tae Jin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 10, 2007
Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta depositionKun Zou, Haruyasu Yamaguchi, Hiroyasu Akatsu, et al.
Cell Reports|July 9, 2013
Prion-like properties of pathological TDP-43 aggregates from diseased brainsTakashi Nonaka, Masami Masuda-Suzukake, Tetsuaki Arai, et al.
Journal of Psychiatric Research|August 4, 2016
Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophreniaMizuki Hino, Yasuto Kunii, Junya Matsumoto, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Journal of Alzheimer'S Disease : JAD|July 13, 2017
Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and HistopathologyAtsushi Niwa, Yuichiro Ii, Akihiro Shindo, et al.
Nature Communications|February 1, 2018
Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathologyKyota Fujita, Xigui Chen, Hidenori Homma, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2017
Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer's pathologyZui Zhang, Yoshiko Takeda-Uchimura, Tahmina Foyez, et al.
Scientific Reports|November 21, 2014
DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's diseaseDai Yuki, Yuki Sugiura, Nobuhiro Zaima, et al.
The Journal of Biological Chemistry|October 5, 2010
Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 functionHirohisa Minagawa, Atsushi Watanabe, Hiroyasu Akatsu, et al.
Acta Neuropathologica|May 5, 2022
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, et al.
Plos One|April 14, 2015
Phosphatidylinositol-glycan-phospholipase D is involved in neurodegeneration in prion diseaseJae-Kwang Jin, Byungki Jang, Hyoung Tae Jin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 10, 2007
Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta depositionKun Zou, Haruyasu Yamaguchi, Hiroyasu Akatsu, et al.
Cell Reports|July 9, 2013
Prion-like properties of pathological TDP-43 aggregates from diseased brainsTakashi Nonaka, Masami Masuda-Suzukake, Tetsuaki Arai, et al.
Journal of Psychiatric Research|August 4, 2016
Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophreniaMizuki Hino, Yasuto Kunii, Junya Matsumoto, et al.
Pageof 17